Cutaneous reactions after treatment with 2-chlorodeoxyadenosine

Acta Dermato-Venereologica

Volumn 76, Issue 5, 1996, Pages 385-386

  Meunier, Philippe ^a   Castaigne, Sylvie ^b   Bastie, Jean Noel ^b   Chosidow, Olivier ^c   Aractingi, Selim ^a  

^a HÔPITAL TENON   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

2 CdA; HCL; Skin manifestation

Indexed keywords

CLADRIBINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; MALE; PRIORITY JOURNAL; RASH; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CLADRIBINE; DRUG ERUPTIONS; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; LYMPHOPENIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0029799412     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Beutler E. Cladribine (2-chlorodeoxyadenosine). Lancet 1992; 340: 952-956.
2. Saven A, Piro L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Mcd 1994; 330: 691-697.
3. Tallman MS, Hakimian D, Variakojis D, Koslow D, Sisney GA, Rademaker AW, et al. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992; 80: 2203-2209.
4. Golomb HM, Catovsky D, Golde DW. Hairy cell leukemia: a five-year update on seventy-one patients. Ann Intern Med 1983; 99: 485-486.
5. Moore N, Paux G, Begaud B, Bouir M, Loupi E, Boismare F, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; (ii): 1056-1058.
6. Piro LD, Miller WE, Carrera CJ, Carson DA, Beutler E. Hairy cell leukemia [Letter]. N Engl J Med 1987; 317: 901.
7. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322: 1117-1121.
8. Saven A, Piro LD. 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia. Cancer Invest 1993; 11: 559-564.
9. Saven A, Piro LD. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycine. Ann Intern Med 1993; 119: 278-283.
10. Hirota Y, Voshioka A, Tanaka S, Watanabe K, Otani T, Minowada J. et al. Imbalance of deoxyribonucleoside triphosphates. DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res 1989; 49: 915-919.
11. Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD. 2-chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia. Leuk Lymphoma 1991; 5 (Suppl): 133-138.
12. Horn TD, Redd JV, Karp JE, Beschorner WE, Burke PJ, Hood AF. Cutaneous eruptions of lymphocyte recovery. Arch Dermatol 1989; 125: 1512-1517.
13. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston collaborative drug surveillance program on 15438 consecutive inpatients. 1975 to 1982. JAMA 1986; 256: 3358-3363.
14. + lymphocyte counts in patients with hairy cell leukemia. Blood 1994; 83: 2906-2911.
15. Thaler J, Grünewald K, Gattringer C, Ho AD, Weyrer K, Dietze O, et al. Long-term follow-up of patients with hairy cell leukemia treated with pentostatin: lymphocyte subpopulations and residual bone-marrow infiltration. Br J Haematol 4993; 84: 75-79.
16. Battegay M, Opravil M, Wüthrich B, Lüthy R. Rash with amoxycillin-clavulanate therapy in HIV-infected patients [Letter]. Lancet 1989; 2: 1100.
17. Chosidow O, Bourgault I, Roujeau JC. Drug rashes. What are the targets of cell-mediated cytotoxicity. Arch Dermatol 1994; 130: 627-629.